New purines and purine analogs as modulators of multidrug resistance

Journal of Medicinal Chemistry

Volumn 39, Issue 20, 1996, Pages 4099-4108

  Dhainaut, Alain ^a   Regnier, Gilbert ^a   Tizot, Andre ^a   Pierre, Alain ^a   Leonce, Stephane ^a   Guilbaud, Nicolas ^a   Kraus Berthier, Laurence ^a   Atassi, Ghanem ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 BIS(ALLYLAMINO) 6 [4 [[2,2 BIS(4 FLUOROPHENYL)ETHYL]AMINO]PIPERIDINO] 1,3,5 TRIAZINE; CALCIUM CHANNEL; CYCLOSPORIN A; DOXORUBICIN; GLYCOPROTEIN P; PURINE DERIVATIVE; VERAPAMIL; VINCRISTINE;

ALKYLATION; ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SENSITIZATION; DRUG SYNTHESIS; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; CALCIUM CHANNELS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; FEMALE; LEUKEMIA P388; LEUKEMIA, EXPERIMENTAL; MICE; MOLECULAR STRUCTURE; NEOPLASM TRANSPLANTATION; P-GLYCOPROTEIN; PIPERIDINES; PURINES; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZINES; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0029839205     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960361i     Document Type: Article

References (25)

1. Dhainaut, A.; Régnier, G.; Atassi, G.; Pierré, A.; Léonce, S.; Kraus-Berthier, L.; Prost, J. F. New Triazine Derivatives as Potent Modulators of Multidrug Resistance. J. Med. Chem. 1992, 35, 2481-2496.
2. Terret, C.; Goncalves, E.; Ruffie, P.; Sarkany, M.; Giroux, B.; Lucas, C.; Funck-Brentano, C.; Armand, J. P. Specific Methodology for a Phase I Trial with Unusual Side-effect: S9788. 9th NCI-EORTC Symposium on New Drugs in Cancer Therapy, 1996; Abstract 438.
3. Terret, C.; Le Cesne, A.; Lagarde, N.; Di Palma, M.; Goncalves, E.; N'Dom, P.; Yataghene, Y.; Funck-Brentano, C.; N'Guyen, J. P.; Marino, J. P.; Besse, B.; Armand, J. P.; Le Chevalier, T.; Belpomme, D.; Misset, J. L.; D'Agay, L.; Berger, E.; Sarkany, M.; Giroux, B. S 9788 a multidrug resistance (MDR) reversing agent: French phase I studies with a 6 h continuous infusion schedule in combination with chemotherapy in patients with refractory cancer. Proc. Am. Assoc. Cancer Res. 1996, 37, 165, Abstract #1139.
4. El-Sherif, N. Early Afterdepolarizations and Arrhythmogenesis. Experimental and Clinical Aspects. Arch. Mal. Coeur. 1991, 84 (2), 227-234.
5. Franz, M. R.; Koller, B.; Woosley, R. L. Pharmacologic therapy in cardiac arrhythmias. In Cardiovascular Pharmacology and Therapeutics; Bramah, Singh, N., Dzan, V. J., Vanhoutte, P. M., Woosley, R. L., Eds.; Churchill Livingstone Inc.: Edinburgh, U.K., 1994; pp 595-616.
6. Jaillon, P.; Simon, T. Les effets pro-arythmiques ventriculaires des médicaments antiarythmiques. (Ventricular proarrhythmic effects of antiarrhytmic drugs.) Therapie 1992, 47, 187-192.
7. Somberg, J. C. Calcium channel blockers that prolong the QT interval. Am. Heart J. 1985, 110, 416-421.
8. Mitsunobu, O. The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products. Synthesis 1981, 1-28.
9. Kazimierczuk, Z.; Cottam, H. B.; Revankar, G. R.; Robins, R. K. Synthesis of 2′-Deoxytubercidin, 2′-Deoxyadenosine, and Related 2′-Deoxynucleosides via a Novel Direct Stereospecific Sodium Salt Glycosylation Procedure. J. Am. Chem. Soc. 1984, 106, 6379-6382.
10. Robins, R. K. Potential Purine Antagonists. IX. Further Studies of Some 4,6-Disubstituted Pyrazolo[3,4-d]pyrimidines. J. Am. Chem. Soc. 1957, 79, 6407-6415.
11. Pierré, A.; Dunn, T. A.; Kraus-Berthier, L.; Léonce, S.; Saint-Dizier, D.; Régnier, G.; Dhainaut, A.; Berlion, M.; Bizzari, J. P.; Atassi, G. In vitro and In vivo Circumvention of Multidrug Resistance by Servier 9788, a Novel Triazinoaminopiperidine Derivative. Invest. New Drugs 1992, 10, 137-148.
12. Pérez, V.; Pierré, A.; Léonce, S.; Anstett, M.; Atassi, G. Effect of Duration of Exposure to S9788, Cyclosporin A or Verapamil on Sensitivity of Multidrug Resistant Cells to Vincristine or Doxorubicin. Anticancer Res. 1993, 13, 985-990.
13. Léonce, S.; Pierré, A.; Anstett, M.; Pérez, V.; Genton, A.; Bizzari, J. P.; Atassi, G. Effects of a New Triazinoaminopiperidine Derivative on Adriamycin Accumulation and Retention in Cells Displaying P-glycoprotein-mediated Multidrug Resistance. Biochem. Pharmacol. 1992, 44 (9), 1707-1715.
14. Beck, W. T.; Qian, X. D. Photoaffinity substrates for P-glycoprotein. Biochem. Pharmacol. 1992, 43, 89-93.
15. Beck, W. T.; Qian, X. D. Binding of an optically pure photoaffinity analog of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant human leukemic cell lines. Cancer Res. 1990, 50, 1132-1137.
16. Striessnig, J.; Knaus, H.; Grabner, M.; Moosburg, K.; Seitz, W.; Leitz, H.; Glossman, H. Photoaffinity labeling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel. FEBS Lett. 1987, 212, 247-253.
17. Pérez, V.; Pierré, A.; Léonce, S.; Anstett, M.; Prost, J. F.; Atassi, G. Caractérisation in vitro de l'Activité du S9788, un Nouveau Modulateur de la Résistance Multidrogue. (In vitro activity of S9788 on MDR cell-lines.) Bull. Cancer 1993, 80, 310-325.
18. Qar, J.; Galizzi, J. P.; Fosset, M.; Lazdinski, M. Receptors for Diphenylbutylpiperidine Neuroleptics in Brain, Cardiac and Smooth Muscle Membranes. Relations with Receptors for 1,4-Dihydropyridines and Phenylalkylamines and with Calcium Channel blockade. Eur. J. Pharmacol. 1987, 141, 261-268.
19. Grisar, J. M.; Claxton, G. P.; Wiech, N. L.; Lucas, R. W.; Mackenzie, R. D.; Goldstein, S. Benzhydryl and Fluorenyl Lactamimides with Hypoglycemic, Diuretic, Blood Platelet Aggregation Inhibitory and Anti-inflammatory Activities. J. Med. Chem. 1973, 16, 885-893.
20. Kamoun, A.; Delalleau, B.; Deslandes, A. Tianeptine Isomer for the Treatment of Cognitive and Memory Disorders. Eur. Patent EP 671173; Chem. Abstr. 1995, 123, 266135z.
21. Winter, W.; Thiel, M.; Stach, K.; Schaumann, W.; Ribbentrop, A. Preparation of New Dibenzoxepines. Br. Patent GB 1119329; Chem. Abstr. 1969, 70, 11583p.
22. Seidel, G.; Huigsen, R.; Hill, J. H. M. Medium Sized Rings. XXV. Reaction of 1,2-Benzocycl-1-en-3-ylmethylamine with Nitric Acid. Tetrahedron 1964, 20, 633-640.
23. Malen, C.; Laubie, M. Nouveaux Dérivés à la Dibenzo(c,f)-thiazépine(1,2) et leur Procédé de Préparation. French Patent FR 1566191; Chem. Abstr. 1970, 72, 100780j.
24. Winthrop, S. O.; Davis, M. A.; Myers, G. S.; Gavin, J. G.; Thomas, R.; Barber, R. New Psychotropic Agents. Derivatives of Dibenzo-[a,d]-1,4-cycloheptadiene. J. Org. Chem. 1962, 27, 230-240.
25. Wright, G. E.; Brown, N. C. Inhibitors of Bacillus subtilis DNA Polymerase III. 6-Anilinouracils and 6-(Alkylamino)uracils. J. Med. Chem. 1980, 23, 34-38.